BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30270253)

  • 1. Evaluation of Red Degeneration of Uterine Leiomyoma with Susceptibility-weighted MR Imaging.
    Takeuchi M; Matsuzaki K; Bando Y; Harada M
    Magn Reson Med Sci; 2019 Apr; 18(2):158-162. PubMed ID: 30270253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological findings of uterine tumors preoperatively diagnosed as red degeneration of leiomyoma by MRI.
    Nakai G; Yamada T; Hamada T; Atsukawa N; Tanaka Y; Yamamoto K; Higashiyama A; Juri H; Nakamoto A; Yamamoto K; Hirose Y; Ohmichi M; Narumi Y
    Abdom Radiol (NY); 2017 Jul; 42(7):1825-1831. PubMed ID: 28389786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of susceptibility-weighted MR sequence for the evaluation of uterine sarcomas.
    Takeuchi M; Matsuzaki K; Harada M
    Clin Imaging; 2019; 53():143-150. PubMed ID: 30340078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red degeneration of uterine leiomyoma: MR appearance.
    Kawakami S; Togashi K; Konishi I; Kimura I; Fukuoka M; Mori T; Konishi J
    J Comput Assist Tomogr; 1994; 18(6):925-8. PubMed ID: 7962801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility weighted MRI after uterine artery embolization for leiomyoma.
    Yamahana Y; Katsumori T; Miura H; Asai S; Yamada S; Takahata A; Yamada K
    Magn Reson Imaging; 2019 May; 58():32-37. PubMed ID: 30654161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine smooth muscle tumours with hyperintense area on T
    Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
    Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine fibroids: Influence of "T2-Rim sign" on immediate therapeutic responses to magnetic resonance imaging-guided high-intensity focused ultrasound ablation.
    Yeo SY; Kim YS; Lim HK; Rhim H; Jung SH; Hwang NY
    Eur J Radiol; 2017 Dec; 97():21-30. PubMed ID: 29153363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Explorative Investigation of Whole-Lesion Histogram MRI Metrics for Differentiating Uterine Leiomyomas and Leiomyosarcomas.
    Gerges L; Popiolek D; Rosenkrantz AB
    AJR Am J Roentgenol; 2018 May; 210(5):1172-1177. PubMed ID: 29547053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
    Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
    Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leiomyoma or sarcoma? MRI performance in the differential diagnosis of sonographically suspicious uterine masses.
    Valletta R; Corato V; Lombardo F; Avesani G; Negri G; Steinkasserer M; Tagliaferri T; Bonatti M
    Eur J Radiol; 2024 Jan; 170():111217. PubMed ID: 38042020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can a T2 hyperintense rim sign differentiate uterine leiomyomas from other solid adnexal masses?
    Reiter MJ; Schwope RB; Lisanti CJ; Banks NB
    Abdom Imaging; 2015 Oct; 40(8):3182-90. PubMed ID: 26205993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
    Kusunoki S; Terao Y; Ujihira T; Fujino K; Kaneda H; Kimura M; Ota T; Takeda S
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):508-513. PubMed ID: 28805609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR Imaging Findings of Uterine Adenomatoid Tumors.
    Takeuchi M; Matsuzaki K; Bando Y; Harada M
    Magn Reson Med Sci; 2024 Apr; 23(2):127-135. PubMed ID: 36697028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial stromal sarcoma located in the myometrium with a low-intensity rim on T2-weighted images: report of three cases and literature review.
    Furukawa R; Akahane M; Yamada H; Kiryu S; Sato J; Komatsu S; Inoh S; Yoshioka N; Maeda E; Takazawa Y; Ohtomo K
    J Magn Reson Imaging; 2010 Apr; 31(4):975-9. PubMed ID: 20373443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine leiomyoma: correlation between signal intensity on magnetic resonance imaging and pathologic characteristics.
    Swe TT; Onitsuka H; Kawamoto K; Ueyama T; Tsuruchi N; Masuda K
    Radiat Med; 1992; 10(6):235-42. PubMed ID: 1287735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-signal-intensity rim surrounding uterine leiomyomas on MR images: pathologic correlation.
    Mittl RL; Yeh IT; Kressel HY
    Radiology; 1991 Jul; 180(1):81-3. PubMed ID: 2052728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR detection of degenerating uterine leiomyomas.
    Okizuka H; Sugimura K; Takemori M; Obayashi C; Kitao M; Ishida T
    J Comput Assist Tomogr; 1993; 17(5):760-6. PubMed ID: 8370831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization.
    Chung YJ; Kang SY; Chun HJ; Rha SE; Cho HH; Kim JH; Kim MR
    Int J Med Sci; 2018; 15(14):1771-1777. PubMed ID: 30588202
    [No Abstract]   [Full Text] [Related]  

  • 19. Magnetic Resonance Signal Intensity Ratio Measurement Before Uterine Artery Embolization: Ability to Predict Fibroid Size Reduction.
    Duvnjak S; Ravn P; Green A; Andersen PE
    Cardiovasc Intervent Radiol; 2017 Dec; 40(12):1839-1844. PubMed ID: 28597064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging features of uterine adenomyomas.
    Song SE; Sung DJ; Park BJ; Kim MJ; Cho SB; Kim KA
    Abdom Imaging; 2011 Aug; 36(4):483-8. PubMed ID: 20652694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.